Mozambique
Tuberculosis profile
| High TB burden | High HIV burden |
Population  2012 25 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 13 (0.98–41) 53 (3.9–163)
Mortality (HIV+TB only) 45 (35–53) 177 (138–209)
Prevalence  (includes HIV+TB) 140 (28–340) 553 (111–1 342)
Incidence  (includes HIV+TB) 140 (96–190) 552 (383–753)
Incidence (HIV+TB only) 83 (58–110) 330 (228–450)
Case detection, all forms (%) 34 (25–50)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 20 951 (45) Relapse 1 451 (32)
Smear-negative 19 797 (43) Treatment after failure 243 (5)
Smear-unknown / not done     Treatment after default 248 (5)
Extrapulmonary 5 542 (12) Other 2 595 (57)
Other 0 (0)      
Total new 46 290   Total retreatment 4 537  
           
Other (history unknown) 0        
Total new and relapse 47 741   Total cases notified 50 827  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio      
Age < 15   2 506 841
Laboratories 2012
Smear (per 100 000 population) 1.2
Culture (per 5 million population) 0.6
Drug susceptibility testing (per 5 million population) 0.4
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status 47 960 (94)
HIV-positive TB patients 27 979 (58)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 27 319 (98)
HIV-positive TB patients on antiretroviral therapy (ART) 15 391 (55)
HIV-positive people screened for TB    
HIV-positive people provided with IPT 17 317  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 3.5 (2.2–4.8) 12 (0–25)
MDR-TB cases among notified pulmonary
TB cases
1 400 (900–2 000) 540 (0–1 100)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 205 (<1%) 243 (5%) 448
Laboratory-confirmed MDR-TB cases 44 136 266
Patients started on MDR-TB treatment     213
Financing TB control 2013
National TB programme budget (US$ millions) 11
% Funded domestically 19%
% Funded internationally 51%
% Unfunded 30%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data